Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Antonio, TX
NPI
1154578078
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
720 Pleasanton Rd
San Antonio, TX, 78214
Phone (210) 921-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,406
1,623 services
Medicare patients, 2024
41
Average age 75
Drug cost, 2024
$3.8M
4,203 prescriptions
Company payments, 2025
$1,657
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luis C Anaya Hoyos was code 99214 (office e&m - established), 37 times for 24 patients. In total Luis C Anaya Hoyos billed 1,623 services in 17 codes, and Medicare paid $6,406.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 37 | 24 | $88.50 | $3,274 |
| 99213 Office E&M - Established | Office | 19 | 15 | $61.22 | $1,163 |
By year: 2022 $11K for 2,497 services; 2023 $8,338 for 2,413 services; 2024 $6,406 for 1,623 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 12 | 12 | $3.21 | $38.52 |
Medicare prescription drug claims, 2024
In 2024, the drug Luis C Anaya Hoyos prescribed most often to Medicare patients was Ozempic (Semaglutide), with 424 prescriptions and refills. In total Luis C Anaya Hoyos wrote 4,203 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 424 | 562 | 100 | $548K |
| Mounjaro Tirzepatide | 386 | 440 | 82 | $477K |
| Levothyroxine Sodium Generic | 216 | 563 | 71 | $1,693 |
| Jardiance Empagliflozin | 167 | 441 | 64 | $269K |
| Trulicity Dulaglutide | 154 | 330 | 49 | $339K |
| Prolia Denosumab | 123 | 735 | 74 | $218K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 118 | 287 | 40 | $97K |
| Pioglitazone Hcl Generic | 112 | 333 | 50 | $2,213 |
| Methimazole Generic | 101 | 256 | 38 | $691 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 98 | 255 | 37 | $18K |
| Tresiba Flextouch U-100 Insulin Degludec | 97 | 222 | 30 | $72K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 84 | 201 | 29 | $88K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 81 | 157 | 33 | $105K |
| Metformin Hcl Er Metformin Hcl | 77 | 189 | 27 | $1,234 |
| Farxiga Dapagliflozin Propanediol | 77 | 167 | 21 | $96K |
Brand drugs: 2,839 claims; generic drugs: 1,085 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis C Anaya Hoyos $1,657 ($1,657 in general payments such as food, travel and fees) from 22 companies. The largest payer was Corcept Therapeutics with $260.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 13 | $260 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 14 | $250 |
| Novo Nordisk Inc NVO | 11 | $237 |
| Radius Health, Inc. | 8 | $150 |
| Incyte Corporation INCY | 1 | $125 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $82.87 |
| Dexcom, Inc. DXCM | 3 | $67.88 |
| Insulet Corporation PODD | 3 | $60.28 |
| Madrigal Pharmaceuticals MDGL | 3 | $59.92 |
| Kyowa Kirin, Inc. 4151.T | 2 | $50.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.